Cardiac Neurodevelopmental Outcome Collaborative is located in Richmond, VA. The organization was established in 2016. According to its NTEE Classification (G43) the organization is classified as: Heart & Circulatory System Diseases & Disorders, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cardiac Neurodevelopmental Outcome Collaborative is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE CNOC IS A NOT-FOR-PROFIT ORGANIZATION ESTABLISHED TO DETERMINE AND IMPLEMENT BEST PRACTICES OF NEURODEVELOPMENTAL AND PSYCHOSOCIAL SERVICES FOR INDIVIDUALS WITH PEDIATRIC AND CONGENITAL HEART DISEASE AND THEIR FAMILIES THROUGH CLINICAL, QUALITY IMPROVEMENT, AND RESEARCH INITIATIVES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROVIDE TRAINING, EDUCATION, AND RELEVANT INFORMATION TO MEMBERS THROUGH PUBLICATIONS, THE ANNUAL SYMPOSIUM, AND THE WEBSITE AND TO FOSTER COMMUNITY OUTREACH THROUGH THESE SAME FORUMS.
CNOC'S NEURODEVELOPMENTAL CORE LAB (NDC) AND DATA ANALYSIS CORE (DAC) ARE RESEARCHING THE DEVELOPMENT OF INFANTS, TODDLERS AND PRESCHOOLERS WHO HAVE UNDERGONE NEONATAL CARDIAC SURGERY USING A LIMITED LIST OF DEMOGRAPHIC, NEURODEVELOPMENTAL, MEDICAL HISTORY AND SURGICAL VARIABLES. AS INITIAL AIMS ARE ACHIEVED, NEURODEVELOPMENTAL TESTING OUTCOMES, QUALITY OF LIFE OUTCOMES AND MEDICAL HISTORY DATA WILL BE ADDED TO THESE EFFORTS.
THE PURPOSE OF THE INAUGURAL CNOC INVESTIGATOR AWARD IS TO PROVIDE FUNDING SUPPORT FOR CNOC MEMBERS TO LEVERAGE THE CNOC INFRASTRUCTURE TO CONDUCT RESEARCH AND/OR QUALITY IMPROVEMENT SCIENCE AIMED AT IMPROVING NEURODEVELOPMENTAL, PSYCHOSOCIAL OUTCOMES, AND/OR QUALITY OF LIFE FOR CHILDREN AND FAMILIES AFFECTED BY CONGENITAL HEART DISEASE (CHD).
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Shabnam Peyvandi Co-Chair | OfficerTrustee | 5 | $0 |
Kelly Wolfe Co-Chair | OfficerTrustee | 5 | $0 |
Cynthia Ortinau Co-Vice Chair | OfficerTrustee | 5 | $0 |
Nadine Kasparian Co-Vice Chair | OfficerTrustee | 5 | $0 |
Sarah Kelly Secretary | OfficerTrustee | 5 | $0 |
Anjali Sadhwani Treasurer | OfficerTrustee | 5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $204,300 |
Investment income | $4,769 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$190 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $208,879 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $40,860 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $2,080 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $6,193 |
Information technology | $19,207 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $8,607 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $707 |
All other expenses | $16 |
Total functional expenses | $98,798 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $399,584 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $1,955 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $83,972 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $485,511 |
Accounts payable and accrued expenses | $1,968 |
Grants payable | $0 |
Deferred revenue | $50,000 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $51,968 |
Net assets without donor restrictions | $433,543 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $485,511 |